Discover 3,591 paid clinical trials in Fullerton, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,591
Active & Responsive
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
for
Castration Resistant Metastatic Prostate Cancer,
Location: Irvine CA, Omaha NE, Kansas City KS, Grand Rapids MI,
Sponsor: Aktis Oncology, Inc.
Sex: Male
Age: 18+
Code: NCT07581184
Phase 1, Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Newport Beach CA, Los Angeles CA, Pasadena CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase 3, Recruiting
Active & Responsive
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
for
Type 1 Diabetes Mellitus, T1D, T1DM,
Location: Newport Beach CA, San Diego CA, Walnut Creek CA,
Sponsor: COUR Pharmaceutical Development Company, Inc.
Sex: All
Age: 12 - 35
Code: NCT06783309
Phase 1, Phase 2, Recruiting
Active & Responsive
IKS014 in Advanced Solid Tumors That Express HER2
for
Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
Location: Newport Beach CA, Fort Worth TX, Nashville TN,
Sponsor: Iksuda Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT05872295
Phase 1, Recruiting
Active & Responsive
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
for
Type 1 Diabetes
Location: Newport Beach CA, Chicago IL, Atlanta GA, Detroit MI,
Sponsor: Indiana University
Sex: All
Age: 18+
Code: NCT07676565
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Newport Beach CA, Los Angeles CA, La Jolla CA,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT05303519
Phase 3, Recruiting
Active & Responsive
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
for
Ulcerative Colitis
Location: Newport Beach CA, Los Angeles CA, Sun City AZ,
Sponsor: Takeda
Sex: All
Age: 18 - 65
Code: NCT06095128
Recruiting
Active & Responsive
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for
Extensive Stage-small Cell Lung Cancer
Location: Newport Beach CA, Phoenix AZ, Vancouver WA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06362252
Phase 1, Phase 2, Recruiting
Active & Responsive
Blood and Cystic Fluid From Patients Undergoing Surgery for Worrisome Pancreatic Cysts
for
Pancreatic Cyst
Location: Newport Beach CA, Atlanta GA
Sponsor: Translational Genomics Research Institute
Sex: All
Age: 18+
Code: NCT07767227
Recruiting
Active & Responsive
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Duarte CA, San Diego CA, Las Vegas NV, Phoenix AZ,
Sponsor: Immuneering Corporation
Sex: All
Age: 18+
Code: NCT07562152
Phase 3, Recruiting
Active & Responsive
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
for
Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness,
Location: Duarte CA, San Francisco CA, Vancouver, Dallas TX,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 65
Code: NCT04786262
Phase 3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Duarte CA, Irvine CA, Los Angeles CA, Las Vegas NV,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
for
Ductal Carcinoma in Situ
Location: Duarte CA, Irvine CA, South Pasadena CA, Los Angeles CA,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: Female
Age: 18+
Code: NCT06075953
Phase 2, Recruiting
Active & Responsive
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
for
Myelofibrosis; Anemia, Anemia, Myelofibrosis,
Location: Duarte CA, Irvine CA, Los Angeles CA, Gilbert AZ,
Sponsor: Disc Medicine, Inc
Sex: All
Age: 18+
Code: NCT05320198
Phase 1, Phase 2, Recruiting
Active & Responsive
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
for
Prostate Carcinoma
Location: Duarte CA, San Francisco CA, Portland OR, Seattle WA,
Sponsor: University of Washington
Sex: Male
Age: 40+
Code: NCT04472338
Recruiting
Active & Responsive
Study of REM-422 in Patients With AML or Higher Risk MDS
for
Myelodysplastic Syndromes,
Location: Duarte CA, Houston TX, Tampa FL, New York NY, Boston MA
Sponsor: Remix Therapeutics
Sex: All
Age: 18+
Code: NCT06297941
Phase 1, Recruiting
Active & Responsive
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
for
Metastatic Hepatocellular Carcinoma,
Location: Duarte CA, Goodyear AZ, Houston TX, Zion IL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06427941
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: Duarte CA, Goodyear AZ, Phoenix AZ, Santa Rosa CA,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07277413
Phase 1, Recruiting
Active & Responsive
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)